Dental Devices include products used for diagnosis of dental ailments and for dental treatment such as oral prophylaxis, dental surgical and restorative interventions. Dental Materials includes Dental Impression Materials, Dental Cement kits and Bonding Agent Kits. GlobalData uses proprietary data and analytics to provide a comprehensive report on the dental materials devices market, including market shares of different players within New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the dental materials market in New Zealand was Kerr followed by 3M and Dentsply Sirona.
Dental Impression Material is used to create negative replica of the oral cavity. Dental Cement is a substance used for filling cavities or anchoring crowns, inlays, and other restorations, including veneers, bridges, and implants. Each type of restoration serves to repair, replace, or enhance the function and appearance of damaged or missing teeth.Bonding Agents are resin materials used to create a bond between dentin and enamel.
The value of the dental materials devices market within New Zealand was expected to be over $5m in 2023.
For the latest complete market share analysis of dental materials device market in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
